Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y
Exp Hematol Oncol. 2025; 14(1):8.
PMID: 39871386
PMC: 11771031.
DOI: 10.1186/s40164-025-00597-9.
Wang Q, Li Q, Xu L, Yuan Z, Liu X, Tang M
World J Gastrointest Oncol. 2025; 17(1):99376.
PMID: 39817136
PMC: 11664625.
DOI: 10.4251/wjgo.v17.i1.99376.
Weng Y, Yan X, Chen B, Bian Z, Ge Y, Lu H
Genes Dis. 2024; 12(2):101319.
PMID: 39634130
PMC: 11615109.
DOI: 10.1016/j.gendis.2024.101319.
Zhang X, Zhang H, Feng J, Tang X, Zhao M, Chen G
Transl Cancer Res. 2024; 13(9):4625-4638.
PMID: 39430831
PMC: 11483468.
DOI: 10.21037/tcr-24-792.
Zuo H, Ru Y, Gao X, Chen H, Yan Y, Ma X
ACS Med Chem Lett. 2024; 15(8):1205-1212.
PMID: 39140071
PMC: 11318020.
DOI: 10.1021/acsmedchemlett.4c00310.
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy.
Kallingal A, Krzemieniecki R, Maciejewska N, Brankiewicz-Kopcinska W, Baginski M
J Cancer Res Clin Oncol. 2024; 150(7):353.
PMID: 39012375
PMC: 11252209.
DOI: 10.1007/s00432-024-05867-3.
Pan-cancer analysis of telomere maintenance mechanisms.
Hakobyan M, Binder H, Arakelyan A
J Biol Chem. 2024; 300(6):107392.
PMID: 38763334
PMC: 11225560.
DOI: 10.1016/j.jbc.2024.107392.
The research progress on radiation resistance of cervical cancer.
Liang M, Sheng L, Ke Y, Wu Z
Front Oncol. 2024; 14:1380448.
PMID: 38651153
PMC: 11033433.
DOI: 10.3389/fonc.2024.1380448.
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.
Talib W, Awajan D, Alqudah A, Alsawwaf R, Althunibat R, Abu AlRoos M
Molecules. 2024; 29(6).
PMID: 38543009
PMC: 10976257.
DOI: 10.3390/molecules29061373.
The causal relationship between genetically determined telomere length and meningiomas risk.
Yu W, Mei Y, Lu Z, Zhou L, Jia F, Chen S
Front Neurol. 2023; 14:1178404.
PMID: 37693759
PMC: 10484632.
DOI: 10.3389/fneur.2023.1178404.
Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA).
Ali J, Walter M
Cancer Cell Int. 2023; 23(1):197.
PMID: 37679807
PMC: 10483736.
DOI: 10.1186/s12935-023-03041-2.
Gene Therapy Strategies Targeting Aging-Related Diseases.
Yu J, Li T, Zhu J
Aging Dis. 2023; 14(2):398-417.
PMID: 37008065
PMC: 10017145.
DOI: 10.14336/AD.2022.00725.
Activation of PPAR-γ prevents TERT-mediated pulmonary vascular remodeling in MCT-induced pulmonary hypertension.
Hussain T, Chai L, Wang Y, Zhang Q, Wang J, Shi W
Heliyon. 2023; 9(3):e14173.
PMID: 36938425
PMC: 10015197.
DOI: 10.1016/j.heliyon.2023.e14173.
The Role of Telomerase in Breast Cancer's Response to Therapy.
Judasz E, Lisiak N, Kopczynski P, Taube M, Rubis B
Int J Mol Sci. 2022; 23(21).
PMID: 36361634
PMC: 9654063.
DOI: 10.3390/ijms232112844.
Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features.
Xing X, Mu N, Yuan X, Wang N, Juhlin C, Straat K
Cancers (Basel). 2022; 14(6).
PMID: 35326537
PMC: 8946831.
DOI: 10.3390/cancers14061385.
In Silico Design, Synthesis, and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity.
Culletta G, Allegra M, Almerico A, Restivo I, Tutone M
Pharmaceuticals (Basel). 2022; 15(1).
PMID: 35056139
PMC: 8778141.
DOI: 10.3390/ph15010082.
Characterization of a newly established schwannoma cell line from a sporadic vestibular schwannoma patient.
Xue L, He W, Wang Z, Chen H, Wang Z, Wu H
Am J Transl Res. 2021; 13(8):8787-8803.
PMID: 34539995
PMC: 8430072.
contributes toward the carcinogenesis of liver cancer and regulates PI3K/Akt/mTOR signaling.
Wang W, Yin Q, Guo S, Wang J
Exp Ther Med. 2021; 22(4):1053.
PMID: 34434267
PMC: 8353638.
DOI: 10.3892/etm.2021.10487.
Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications.
Zielinska A, Szalata M, Gorczynski A, Karczewski J, Eder P, Severino P
Cancers (Basel). 2021; 13(8).
PMID: 33920840
PMC: 8071188.
DOI: 10.3390/cancers13081896.
Telomere Maintenance Pathway Activity Analysis Enables Tissue- and Gene-Level Inferences.
Nersisyan L, Simonyan A, Binder H, Arakelyan A
Front Genet. 2021; 12:662464.
PMID: 33897770
PMC: 8058386.
DOI: 10.3389/fgene.2021.662464.